Oxidative stress and lung function profiles of male smokers free from COPD compared to those with COPD: A case-control study

Libyan Journal of Medicine

Volumn 9, Issue 1, 2014, Pages

  Moussa, Syrine Ben ^a   Sfaxi, Ines ^a   Tabka, Zouhair ^a,b   Saad, Helmi Ben ^a,b,c   Rouatbi, Sonia ^a,b  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b UNIVERSITY OF SOUSSE   (Tunisia)

^c Research Unit: Secondary Prevention After Myocardial Infarction   (Tunisia)

Author keywords

Inflammation; Lung disease; Sedentarily; Spirometry; Stress oxidant; Tobacco

Indexed keywords

GLUTATHIONE; HEMOGLOBIN; MALONALDEHYDE; BIOLOGICAL MARKER; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MALE; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PLETHYSMOGRAPHY; PROTEIN BLOOD LEVEL; SEDENTARY LIFESTYLE; SMOKING HABIT; TOTAL LUNG CAPACITY; BLOOD; COMPARATIVE STUDY; EXERCISE; EXHALATION; INFLAMMATION; LUNG DISEASE; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; SEDENTARILY; SMOKING; SPIROMETRY; STRESS OXIDANT; TOBACCO;

INFLAMMATION; LUNG DISEASE; SEDENTARILY; SPIROMETRY; STRESS OXIDANT; TOBACCO;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EXERCISE; EXHALATION; FORCED EXPIRATORY VOLUME; GLUTATHIONE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MOTOR ACTIVITY; NITRIC OXIDE; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING; TOTAL LUNG CAPACITY;

EID: 84902593684     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v9.23873     Document Type: Article

References (81)

1. Burney P, Jithoo A, Kato B, Janson C, Mannino D, Nizankowska- Mogilnicka E, et al. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty a BOLD analysis. Thorax. 2014; 69: 465-73.
2. Daldoul H, Denguezli M, Jithoo A, Gnatiuc L, Buist S, Burney P, et al. Prevalence of COPD and tobacco smoking in Tunisia results from the BOLD study. Int J Environ Res Public Health. 2013; 10: 7257-71.
3. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187: 347-65.
4. Ben Saad H, Ben Amor L, Ben Mdella S, Ghannouchi I, Ben Essghair M, Bougmiza I, et al. The diagnosis of COPD is recommendation dependent. Tunis Med. 2014 (In press).
5. Ben Saad H, Hamadou R, Ben Cheikh I, Chouchene A, Rejeb N, Zbidi A, et al. Respiratory rehabilitation of chronic obstructive pulmonary disease patients: preliminary data of Tunisian experience. J Med Rehabil. 2008; 28: 138-47.
6. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005; 2: 258-66.
7. MacNee W, Rahman I. Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends Mol Med. 2001; 7: 55-62.
8. Rahman I, MacNee W. Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radic Biol Med. 1996; 21: 669-81.
9. Doruk S, Ozyurt H, Inonu H, Erkorkmaz U, Saylan O, Seyfikli Z. Oxidative status in the lungs associated with tobacco smoke exposure. Clin Chem Lab Med. 2011; 49: 2007-12.
10. Kanabrocki EL, Ryan MD, Murray D, Jacobs RW, Wang J, Hurder A, et al. Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage, A potential cancer marker? Clin Ter. 2006; 157: 117-22.
11. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005; 2: 50-60.
12. Macnee W, Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 160: S58-65.
13. Chow CK. Nutritional influence on cellular antioxidant defense systems. Am J Clin Nutr. 1979; 32: 1066-81.
14. Abraham P, Wilfred G, Ramakrishna B. Oxidative damage to the hepatocellular proteins after chronic ethanol intake in the rat. Clin Chim Acta. 2002; 325: 117-25.
15. Inonu H, Doruk S, Sahin S, Erkorkmaz U, Celik D, Celikel S, et al. Oxidative stress levels in exhaled breath condensate associated with COPD and smoking. Respir Care. 2012; 57: 413-19.
16. Lodovici M, Casalini C, Cariaggi R, Michelucci L, Dolara P. Levels of 8-hydroxydeoxyguanosine as a marker of DNA damage in human leukocytes. Free Radic Biol Med. 2000; 28: 13-17.
17. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Eng J Med. 1995; 332: 1198-203.
18. Mak JC. Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance. Int J Tuberc Lung Dis. 2008; 12: 368-74.
19. Arja C, Surapaneni KM, Raya P, Adimoolam C, Balisetty B, Kanala KR. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease. Respirology. 2013; 18: 1069-75.
20. Cristovao C, Cristovao L, Nogueira F, Bicho M. Evaluation of the oxidant and antioxidant balance in the pathogenesis of chronic obstructive pulmonary disease. Rev Port Pneumol. 2013; 19: 70-5.
21. Nadeem A, Raj HG, Chhabra SK. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation. 2005; 29: 23-32.
22. Andersson A, Ankerst J, Lindgren A, Larsson K, Hultberg B. Hyperhomocysteinemia and changed plasma thiol redox status in chronic obstructive pulmonary disease. Clin Chem Lab Med. 2001; 39: 229-33.
23. Filaire E, Dupuis C, Galvaing G, Aubreton S, Laurent H, Richard R, et al. Lung cancer: what are the links with oxidative stress, physical activity and nutrition. Lung Cancer. 2013; 82: 383-9.
24. Toledo AC, Magalhaes RM, Hizume DC, Vieira RP, Biselli PJ, Moriya HT, et al. Aerobic exercise attenuates pulmonary injury induced by exposure to cigarette smoke. Eur Respir J. 2012; 39: 254-64.
25. Dutta A, Ray MR, Banerjee A. Systemic inflammatory changes and increased oxidative stress in rural Indian women cooking with biomass fuels. Toxicol Appl Pharmacol. 2012; 261: 255-62.
26. Okubo H, Shaheen SO, Ntani G, Jameson KA, Syddall HE, Aihie Sayer A, et al. Processed meat consumption and lung function: modification by antioxidants and smoking. Eur Respir J. 2014; 43: 972-82.
27. Suresh K, Chandrashekara S. Sample size estimation and power analysis for clinical research studies. J Hum Reprod Sci. 2012; 5: 7-13.
28. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. General considerations for lung function testing. Eur Respir J. 2005; 26: 153-61.
29. Rouatbi S, Chouchene M, Sfaxi I, Ben Rejeb M, Tabka Z, Ben Saad H. Fraction of exhaled nitric oxide (FeNO) norms in healthy tunisian adults. BioMed Res Int. 2014. doi: http://dx. doi.org/10.1155/2014/269670. Available from: www.hindawi. com/journals/bmri/aip/269670 [cited 14 May 2014].
30. Ferris BG. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis. 1978; 118: 1-120.
31. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA. A physical activity questionnaire for the elderly. Med Sci Sports Exerc. 1991; 23: 974-9.
32. Ben Saad H, Tfifha M, Harrabi I, Tabka Z, Guenard H, Hayot M, et al. Factors influencing pulmonary function in Tunisian women aged 45 years and more. Rev Mal Respir. 2006; 23: 324-3800.
33. Tsai AG, Wadden TA. In the clinic: obesity. Ann Intern Med. 2013; 159: ITC3-1-ITC3-15.
34. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med. 1976; 15: 212-16.
35. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968; 25: 192-205.
36. Waggiallah H, Alzohairy M. The effect of oxidative stress on human red cells glutathione peroxidase, glutathione reductase level, and prevalence of anemia among diabetics. N Am J Med Sci. 2011; 3: 344-7.
37. American Thoracic Society/European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005; 171: 912-30.
38. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005; 26: 319-38.
39. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26: 511-22.
40. Ben Saad H, Prefaut C, Tabka Z, Zbidi A, Hayot M. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD. Pulm Pharmacol Ther. 2008; 21: 767-73.
41. Ben Saad H, El Attar MN, Hadj Mabrouk K, Ben Abdelaziz A, Abdelghani A, Bousarssar M, et al. The recent multi-ethnic global lung initiative 2012 (GLI2012) reference values don't reflect contemporary adult's North African spirometry. Respir Med. 2013; 107: 2000-8.
42. Ben Saad H, Ben Amor L, Ben Mdalla S, Ghannouchi I, Ben Essghair M, Sfaxi R, et al. The importance of lung volumes in the investigation of heavy smokers. Rev Mal Respir. 2014; 31: 29-40.
43. Ben Saad H, Khemiss M, Nhari S, Ben Essghaier M, Rouatbi S. Pulmonary functions of narghile smokers compared to cigarette smokers: a case-control study. Libyan J Med. 2013; 8: 22650.
44. Hanta I, Kocabas A, Canacankatan N, Kuleci S, Seydaoglu G. Oxidant-antioxidant balance in patients with COPD. Lung. 2006; 184: 51-5.
45. Ben Saad H, Ben Attia Saafi R, Rouatbi S, Ben Mdella S, Garrouche A, et al. Which definition to use when defining airflow obstruction? Rev Mal Respir. 2007; 24: 323-30.
46. Sutherland TJ, Cowan JO, Young S, Goulding A, Grant AM, Williamson A, et al. The association between obesity and asthma: interactions between systemic and airway inflammation. Am J Respir Crit Care Med. 2008; 178: 469-75.
47. Ghannem H, Hadj Fredj A. Eating habits and cardiovascular risk factors. Epidemiologic study of the Tunisian Sahel. Presse Med. 1999; 28: 1005-8.
48. Franssen FM, O'Donnell DE, Goossens GH, Blaak EE, Schols AM. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008; 63: 1110-17.
49. Rahman I. The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med. 2005; 4: 175-200.
50. Clini E, Bianchi L, Pagani M, Ambrosino N. Endogenous nitric oxide in patients with stable COPD: correlates with severity of disease. Thorax. 1998; 53: 881-3.
51. Ansarin K, Chatkin JM, Ferreira IM, Gutierrez CA, Zamel N, Chapman KR. Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function. Eur Respir J. 2001; 17: 934-8.
52. Ziora D, Dworniczak S, Kaczmarczyk G, Jastrzebski D, Krzywiecki A, Kozielski J. Correlation of exhaled nitric oxide with nitrogen oxides and selected cytokines in induced sputum of chronic obstructive pulmonary disease patients. J Physiol Pharmacol. 2007; 58(Suppl 5): 791-9.
53. Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mark TW, Koeter GH, et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax. 2000; 55: 12-18.
54. Kanazawa H, Shoji S, Yoshikawa T, Hirata K, Yoshikawa J. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease. Clin Exp Allergy. 1998; 28: 1244-50.
55. Delen FM, Sippel JM, Osborne ML, Law S, Thukkani N, Holden WE. Increased exhaled nitric oxide in chronic bronchitis: comparison with asthma and COPD. Chest. 2000; 117: 695-701.
56. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157: 998-1002.
57. Olin AC, Andelid K, Vikgren J, Rosengren A, Larsson S, Bake B, et al. Single breath N2-test and exhaled nitric oxide in men. Respir Med. 2006; 100: 1013-19.
58. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011; 184: 602-15.
59. Morrison D, Rahman I, Lannan S, MacNee W. Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med. 1999; 159: 473-9.
60. Bloomer RJ. Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarette smokers compared to nonsmokers: impact of dietary intake. Nutr J. 2007; 6: 39.
61. Reddy S, Finkelstein EI, Wong PS, Phung A, Cross CE, van der Vliet A. Identification of glutathione modifications by cigarette smoke. Free Radic Biol Med. 2002; 33: 1490-8.
62. Vina J, Servera E, Asensi M, Sastre J, Pallardo FV, Ferrero JA, et al. Exercise causes blood glutathione oxidation in chronic obstructive pulmonary disease: prevention by O2 therapy. J Appl Physiol (1985). 1996; 81: 2198-202.
63. Calikoglu M, Unlu A, Tamer L, Ercan B, Bugdayci R, Atik U. The levels of serum vitamin C, malonyldialdehyde and erythrocyte reduced glutathione in chronic obstructive pulmonary disease and in healthy smokers. Clin Chem Lab Med. 2002; 40: 1028-31.
64. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59: 574-80.
65. Gould NS, Min E, Gauthier S, Martin RJ, Day BJ. Lung glutathione adaptive responses to cigarette smoke exposure. Respir Res. 2011; 12: 133.
66. Jackson AA, Gibson NR, Lu Y, Jahoor F. Synthesis of erythrocyte glutathione in healthy adults consuming the safe amount of dietary protein. Am J Clin Nutr. 2004; 80: 101-7.
67. Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A, et al. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax. 2005; 60: 293-300.
68. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med. 1996; 154: 1055-60.
69. Woodruff PG, Koth LL, Yang YH, Rodriguez MW, Favoreto S, Dolganov GM, et al. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med. 2005; 172: 1383-92.
70. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002; 82: 47-95.
71. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006; 160: 1-40.
72. Ahmad A, Shameem M, Husain Q. Altered oxidant-antioxidant levels in the disease prognosis of chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2013; 17: 1104-9.
73. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994; 233: 357-63.
74. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003; 329: 23-38.
75. Nagler R, Lischinsky S, Diamond E, Drigues N, Klein I, Reznick AZ. Effect of cigarette smoke on salivary proteins and enzyme activities. Arch Biochem Biophys. 2000; 379: 229-36.
76. Dweik RA, Sorkness RL, Wenzel S, Hammel J, Curran-Everett D, Comhair SA, et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med. 2010; 181: 1033-41.
77. Robbins RA, Millatmal T, Lassi K, Rennard S, Daughton D. Smoking cessation is associated with an increase in exhaled nitric oxide. Chest. 1997; 112: 313-18.
78. Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004; 18: 1791-800.
79. Rolin S, Masereel B, Dogne JM. Prostanoids as pharmacological targets in COPD and asthma. Eur J Pharmacol. 2006; 533: 89-100.
80. Garcia-Rio F, Romero D, Lores V, Casitas R, Hernanz A, Galera R, et al. Dynamic hyperinflation, arterial blood oxygen, and airway oxidative stress in stable patients with COPD. Chest. 2011; 140: 961-9.
81. Ben Saad H, Prefaut C, Tabka Z, Mtir AH, Chemit M, Hassaoune R, et al. 6-minute walk distance in healthy North Africans older than 40 years: influence of parity. Respir Med. 2009; 103: 74-84.